| Investors Unimpressed By Abbott |
Forbes, NY - 51 minutes ago
Despite beating expectations and raising guidance, Abbott Laboratories couldn't win over the hearts of investors on Wednesday. Shares of Abbott Laboratories ...
|
| Earnings stink, but... |
CNNMoney.com - 56 minutes ago
Drug and medical equipment maker Abbott Laboratories reported a more than 50% jump in profits Wednesday thanks to strong sales of arthritis drug Humira, ...
|
| NH Supreme Court dismisses school funding suit |
WBZ, MA - 1 hour ago
However, the company licenses Promus from Abbott Laboratories, which collects 40 percent of the revenue on sales of the products. Leerink Swann analyst Rick ...
|
| UPDATE: Taxus More Effective Vs Bare Stent For Heart Attacks |
CNNMoney.com - 1 hour ago
Along with Boston Scientific , other companies in the US stent market include Johnson & Johnson (JNJ), Abbott Laboratories (ABT) and Medtronic Inc. (MDT). ...
|
| Abbott Labs Numbers Make it a Force in the Stent Market (ABT) |
Dividend.com, NJ - 1 hour ago
By Dividend.com Staff Abbott Laboratories (ABT) just reported a big jump in third quarter profit, thanks to strong sales of its arthritis medication Humira ...
|
| Analyst Reports for The Procter & Gamble Company, Health ... |
Trading Markets (press release), CA - 1 hour ago
... Health Management Associates Inc. (NYSE: HMA), Chevron Corporation (NYSE: CVX | Quote | Chart | News | PowerRating) and Abbott Laboratories (NYSE: ABT) ...
|
| Abbott Laboratories (ABT) NewsBite |
Market Intelligence Center, VA - 2 hours ago
Abbott Laboratories (ABT) was covered in a Bloomberg Video Report today and the stock is now at $54.11, down $0.67 (-1.22%) on volume of 4173047 shares ...
|
